Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 496 | 504 | 1,532 | 576 | 663 |
| Gross Profit | 496 | 504 | 1,532 | 576 | 663 |
| Operating Expenses | 5,252 | 4,808 | 5,325 | 4,113 | 3,865 |
| Operating Income | -4,757 | -4,304 | -3,794 | -3,537 | -3,203 |
| Other Income | 1,014 | 562 | 541 | 128 | 154 |
| Pre-tax Income | -3,743 | -3,741 | -3,252 | -3,409 | -3,049 |
| Net Income Continuous | -3,743 | -3,741 | -3,252 | -3,409 | -3,049 |
| Net Income | $-3,743 | $-3,741 | $-3,252 | $-3,409 | $-3,049 |
| EPS Basic Total Ops | -4.32 | -4.80 | -7.68 | -5.28 | -4.80 |
| EPS Basic Continuous Ops | -4.42 | -4.77 | -4.45 | -5.30 | -4.79 |
| EPS Diluted Total Ops | -4.32 | -4.80 | -7.68 | -5.28 | -4.80 |
| EPS Diluted Continuous Ops | -4.42 | -4.77 | -4.45 | -5.30 | -4.79 |
| EBITDA(a) | $-4,523 | $-4,073 | $-3,587 | $-3,292 | $-2,991 |